Rockefeller Capital Management’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1
Closed 2008
2022
Q4
$0 Sell
1
-30
-97% -$14.1K ﹤0.01% 3818
2022
Q3
$18K Sell
31
-11
-26% -$6.59K ﹤0.01% 2810
2022
Q2
$22K Buy
42
+7
+20% +$3.54K ﹤0.01% 2681
2022
Q1
$21K Buy
35
+28
+400% +$14.4K ﹤0.01% 2691
2021
Q4
$4K Buy
+7
New +$4.26K ﹤0.01% 3322

Other funds holding AGL

Rockefeller Capital Management's AGL Position: Q1 2023 in Review

Rockefeller Capital Management sold out of Agilon Health (AGL) in Q1 2023, closing a stake of 1 share.

Rockefeller Capital Management first reported a position in AGL in Q4 2021 and held it in 5 quarters. The position peaked at $22K in Q2 2022. 198 funds tracked by Wall St. Rank hold AGL as of Q1 2023.

  • Rockefeller Capital Management reported no remaining Agilon Health position as of Q1 2023 after selling out during the quarter.
  • Rockefeller Capital Management sold 1 Agilon Health share in Q1 2023.
  • Rockefeller Capital Management first reported a position in Agilon Health in Q4 2021 and held it in 5 quarters.
  • Rockefeller Capital Management's Agilon Health position peaked at $22K in Q2 2022.
  • 198 funds tracked by Wall St. Rank held Agilon Health as of Q1 2023.

Based on Rockefeller Capital Management's 13F filing for Q1 2023, filed 16 May 2023.